56.45 USD
↗ 0.78 (1.40%)AT CLOSE (11:59 AM EDT)
Bristol-Myers Squibb Co.
BMYNYSE • USD
56.52
↗ 0.07 (0.12%)
POST MARKET (AS OF 08:15 PM EDT)
Post Market
AS OF 08:15 PM EDT
56.52
↗ 0.07 (0.12%)
Market: CLOSED
Open?$56.01
High?$57.02
Low?$55.45
Prev. Close?$55.67
Volume?9.3M
Avg. Volume?10.4M
VWAP?$56.45
Rel. Volume?0.89x
Bid / Ask
Bid?$56.14 × 100
Ask?$56.45 × 100
Spread?$0.31
Midpoint?$56.30
Valuation & Ratios
Market Cap?113.7B
Shares Out?2.0B
Float?2.0B
Float %?99.9%
P/E Ratio?15.63
P/B Ratio?5.66
EPS?$3.56
Dividend?4.46%
Ex-Dividend?N/A
News
Profile
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Themes
Address
ROUTE 206 AND PROVINCE LINE ROAD
PRINCETON, NJ 08543
Phone: (609) 252-4621
PRINCETON, NJ 08543
Phone: (609) 252-4621
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?1.42Adequate
Quick Ratio?1.28Adequate
Cash Ratio?0.50Adequate
Debt/Equity?2.22High
ValuationATTRACTIVELY VALUED
Score89/100
P/E?15.6CHEAP▾
P/B?5.66FAIR▾
P/S?2.34CHEAP▾
P/FCF?9.6CHEAP▾
EV/EBITDA?11.0CHEAP▾
EV/Sales?3.06FAIR▾
Returns & Efficiency
ROE?36.3%STRONG▾
ROA?8.4%STRONG▾
Cash Flow & Enterprise
FCF?$11.9B
Enterprise Value?$148.6B
Fundamentals ratios updated end of day